BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 2503976)

  • 1. Comparative intracellular growth of difficult-to-grow and other mycobacteria in a macrophage cell line.
    Rastogi N; Blom-Potar MC; David HL
    Acta Leprol; 1989; 7 Suppl 1():156-9. PubMed ID: 2503976
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differential handling of bacterial antigens in macrophages infected with Mycobacterium leprae as studied by immunogold labeling of ultrathin sections.
    Rastogi N; Cadou S; Hellio R
    Int J Lepr Other Mycobact Dis; 1991 Jun; 59(2):278-91. PubMed ID: 2071985
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Macrophage interaction with mycobacteria including M. leprae.
    Ryter A; Frehel C; Rastogi N; David HL
    Acta Leprol; 1984; 2(2-4):211-26. PubMed ID: 6398582
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Development of infection model for studying intracellular gene expression of Mycobacterium tuberculosis.
    Alli OA; Ogbolu DO; Spreadbury CL
    Afr J Med Med Sci; 2009 Dec; 38(4):325-32. PubMed ID: 20499625
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Differential growth inhibition of mycobacteria by interferon-gamma-or tumor necrosis factor-alpha-treated murine peritoneal macrophages].
    Sato K; Tomioka H; Saito H
    Kekkaku; 1996 Nov; 71(11):607-14. PubMed ID: 8958673
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mycobacterium ulcerans toxic macrolide, mycolactone modulates the host immune response and cellular location of M. ulcerans in vitro and in vivo.
    Adusumilli S; Mve-Obiang A; Sparer T; Meyers W; Hayman J; Small PL
    Cell Microbiol; 2005 Sep; 7(9):1295-304. PubMed ID: 16098217
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In-vitro study of mouse peritoneal macrophage response to virulent and avirulent strains of mycobacteria.
    Negi SS; Bramhne HG; Gupta S; Kumar G; Singh US
    J Commun Dis; 2003 Sep; 35(3):154-61. PubMed ID: 15796407
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vitro control of Mycobacterium bovis by macrophages.
    Aldwell FE; Wedlock DN; Slobbe LJ; Griffin JF; Buddle BM; Buchan GS
    Tuberculosis (Edinb); 2001; 81(1-2):115-23. PubMed ID: 11463232
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparative studies of antigenic glycolipids of mycobacteria related to the leprosy bacillus.
    Minnikin DE; Ridell M; Wallerström G; Besra GS; Parlett JH; Bolton RC; Magnusson M
    Acta Leprol; 1989; 7 Suppl 1():51-4. PubMed ID: 2504005
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Macrophage phagocytosis of virulent but not attenuated strains of Mycobacterium tuberculosis is mediated by mannose receptors in addition to complement receptors.
    Schlesinger LS
    J Immunol; 1993 Apr; 150(7):2920-30. PubMed ID: 8454864
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Growth of mycobacteria in relation to the pH of the medium.
    Portaels F; Pattyn SR
    Ann Microbiol (Paris); 1982; 133(2):213-21. PubMed ID: 7149523
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Distribution of antigenic glycolipids among Mycobacterium tuberculosis strains and their contribution to virulence].
    Fujiwara N
    Kekkaku; 1997 Apr; 72(4):193-205. PubMed ID: 9145649
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparative proteomic analysis of virulent Korean Mycobacterium tuberculosis K-strain with other mycobacteria strain following infection of U-937 macrophage.
    Ryoo SW; Park YK; Park SN; Shim YS; Liew H; Kang S; Bai GH
    J Microbiol; 2007 Jun; 45(3):268-71. PubMed ID: 17618234
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bactericidal activity of 2-nitroimidazole against the active replicating stage of Mycobacterium bovis BCG and Mycobacterium tuberculosis with intracellular efficacy in THP-1 macrophages.
    Khan A; Sarkar S; Sarkar D
    Int J Antimicrob Agents; 2008 Jul; 32(1):40-5. PubMed ID: 18538548
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evidence that host-recycling of Mycobacterium avium preserves its ability to hinder macrophage killing functions.
    Fréhel C; Thorel MF; Rastogi N
    Acta Leprol; 1989; 7 Suppl 1():160-3. PubMed ID: 2503977
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Establishment of an in vitro model using NR8383 cells and Mycobacterium bovis Calmette-Guerin that mimics a chronic infection of Mycobacterium tuberculosis.
    Hino M; Oda M; Yoshida A; Nakata K; Kohchi C; Nishizawa T; Inagawa H; Hori H; Makino K; Terada H; Soma G
    In Vivo; 2005; 19(5):821-30. PubMed ID: 16097433
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Secretion of cytokines by human macrophages upon infection by pathogenic and non-pathogenic mycobacteria.
    Beltan E; Horgen L; Rastogi N
    Microb Pathog; 2000 May; 28(5):313-8. PubMed ID: 10799281
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The acid-induced operon Rv3083-Rv3089 is required for growth of Mycobacterium tuberculosis in macrophages.
    Cheruvu M; Plikaytis BB; Shinnick TM
    Tuberculosis (Edinb); 2007 Jan; 87(1):12-20. PubMed ID: 16893682
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The ESAT-6/CFP-10 secretion system of Mycobacterium marinum modulates phagosome maturation.
    Tan T; Lee WL; Alexander DC; Grinstein S; Liu J
    Cell Microbiol; 2006 Sep; 8(9):1417-29. PubMed ID: 16922861
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interaction of antigen presenting cells with mycobacteria.
    Hope JC; Thom ML; McCormick PA; Howard CJ
    Vet Immunol Immunopathol; 2004 Aug; 100(3-4):187-95. PubMed ID: 15207456
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.